KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Other Operating Expenses (2016 - 2025)

Cme (CME) has disclosed Other Operating Expenses for 17 consecutive years, with $553.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Operating Expenses rose 8.08% to $553.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.9 billion, a 3.83% increase, with the full-year FY2025 number at $2.0 billion, up 3.35% from a year prior.
  • Other Operating Expenses was $553.9 million for Q4 2025 at Cme, up from $467.2 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $553.9 million in Q4 2025 to a low of $407.7 million in Q3 2022.
  • A 5-year average of $453.3 million and a median of $441.8 million in 2021 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: decreased 12.44% in 2021, then rose 8.97% in 2023.
  • Cme's Other Operating Expenses stood at $469.8 million in 2021, then grew by 4.19% to $489.5 million in 2022, then rose by 5.74% to $517.6 million in 2023, then decreased by 0.99% to $512.5 million in 2024, then rose by 8.08% to $553.9 million in 2025.
  • Per Business Quant, the three most recent readings for CME's Other Operating Expenses are $553.9 million (Q4 2025), $467.2 million (Q3 2025), and $464.5 million (Q2 2025).